Those with pre existing psychiatric disorders including major depression should take extra precautions when taking this medication
When Did the FDA Approve Wegovy Pills Novo Nordisk announced FDA approval of the Wegovy pill on December 22, 2025
Patients should discuss reproductive planning with their healthcare provider before starting either medication
However, healthcare professionals usually recommend weaning off semaglutide slowly to minimize spikes in hunger and weight regain
Key drivers of the GLP-1 receptor agonist market include their efficacy in controlling blood sugar levels, additional benefits like weight loss and cardiovascular risk reduction, rising prevalence of type 2 diabetes, and increasing awareness of diabetes management, leading to growing demand for these medications
However, the popularity of GLP-1 drugs has presented a unique opportunity